K. Angela Macfarlane
President & CEO
Ms. Macfarlane joined ForSight Labs as President and CEO in March 2007. Over the past nine years, ForSight has started six ForSight VISION companies, that have collectively raised over $130M in capital, and are focused on breakthrough therapies for ophthalmology, including glaucoma, corneal and cataract surgery and treatment of anterior and posterior segment ocular disorders. Ms. Macfarlane brings over 20 years of experience in early stage company creation in both corporate and incubator settings to ForSight.
Prior to joining the ForSight Labs team full-time, Ms. Macfarlane served as Chief Technology Counsel to The Foundry. From 1999 through 2004, Ms. Macfarlane served as Technology Counsel for Thomas J. Fogarty, MD, a renowned physician/entrepreneur. In addition, Ms. Macfarlane served as in-house counsel at several medical device start-up companies, including TransVascular, Inc., AneuRx, Inc. and VidaMed Inc. Ms. Macfarlane received her BA in Business Administration from San Francisco State University, and her JD from Golden Gate University School of Law.